Their work marks the first published study documenting successful use of the treatment, which has been 13 years in the making, according to The New York Times.
The 58-year-old French man who participated in the study had an inherited form of blindness.
When wearing special light-stimulating goggles, the man was able to perceive and locate objects sitting in front of him on a table.
The gene therapy technique, called optogenetics, entails transforming the eye’s ganglion cells into photoreceptor cells that can detect light by using proteins derived from algae and other microbes.
Researchers said the study establishes proof of concept for future treatments for inherited forms of blindness.
To learn more, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
